Stay informed with the latest litigation news. Explore now

IP Verse

Aripiprazole Prodrug Compositions - EP3182958B2

EP3182958

ALKERMES PHARMA IRELAND
Application Number
EP15750750A
Filing Date
Aug 17, 2015
Status
Patent Maintained As Amended
Apr 15, 2022
Grant Date
May 18, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2445502B2
EP3253377B1
EP2970101B1

Bibliography

The patent EP3182958B2 was granted to Alkermes Pharma Ireland on May 18, 2022 following the initial filing on Aug 17, 2015 under the application number EP15750750A . The current legal status of the patent is Patent Maintained As Amended.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKNov 27, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents